The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 28, 2018
Pfizer announced the Phase 2b trial STRIVE evaluating the company’s investigational Staphylococcus aureus multi-antigen vaccine (PF-06290510) is being...
read more
Thursday, December 27, 2018
On December 21, 2018, the FDA approved ELZONRIS for blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years ...
read more
Wednesday, December 26, 2018
Merck and Pfizer have announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab did not support the ...
read more
Friday, December 21, 2018
Oxford BioTherapeutics has received IND clearance from the FDA for OBT076, an experimental ADC for the treatment of women with high risk HER2 negative...
read more
Wednesday, December 19, 2018
The European Commission has granted marketing authorization for Dengvaxia, Sanofi's dengue vaccine.
read more
Tuesday, December 11, 2018
As we continue to implement our 2018 Compounding Priorities Plan, our mission is to preserve patient access to compounded drugs to meet patients’ ...
read more
Monday, December 10, 2018
Vanda announced Hetlioz (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal ...
read more
Tuesday, December 04, 2018
Alkahest announced dosing of the first subject in a trial of its human plasma fraction, GRF6021, for the treatment of Parkinson's disease with ...
read more
Monday, December 03, 2018
Amgen and UCB announced the FDA BRUDAC will review data supporting the BLA for Evenity for the osteoporosis in postmenopausal women at high risk for ...
read more
Monday, November 26, 2018
CURE has secured a new registration with the Drug Enforcement Administration (DEA) as a manufacturer authorized to handle Schedule 1 controlled ...
read more
Wednesday, November 21, 2018
Daiichi Sankyo announced the FDA has accepted a NDA and granted Priority Review for quizartinib for the treatment of adult patients with relapsed/...
read more
Tuesday, November 20, 2018
The FDA expanded the approved use of Adcetris injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell ...
read more
Thursday, November 08, 2018
Visterra announced the initiation of a Phase 1 clinical study with VIS649 in healthy volunteers.
read more
Monday, November 05, 2018
AcelRx Pharmaceuticals announced the approval of Dsuvia by the FDA.
read more
Friday, November 02, 2018
Alkermes Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder.
read more